{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T04:35:30Z","timestamp":1794198930699,"version":"4.8.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["202006380126"],"award-info":[{"award-number":["202006380126"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EU PANVIPREP"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-52071-5","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T09:19:41Z","timestamp":1725527981000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["A robust mouse model of HPIV-3 infection and efficacy of GS-441524 against virus-induced lung pathology"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7890-8030","authenticated-orcid":false,"given":"Yuxia","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4246-6303","authenticated-orcid":false,"given":"Birgit","family":"Weynand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5708-1321","authenticated-orcid":false,"given":"Manon","family":"Laporte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Coenjaerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5599-1671","authenticated-orcid":false,"given":"Darius","family":"Babusis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4327-1727","authenticated-orcid":false,"given":"John P.","family":"Bilello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8082-4971","authenticated-orcid":false,"given":"Peter","family":"Mombaerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9265-6028","authenticated-orcid":false,"given":"Dirk","family":"Jochmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0033-7514","authenticated-orcid":false,"given":"Johan","family":"Neyts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,5]]},"reference":[{"key":"52071_CR1","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1055\/s-0036-1584798","volume":"37","author":"AR Branche","year":"2016","unstructured":"Branche, A. R. & Falsey, A. R. Parainfluenza virus infection. Semin. Respir. Crit. Care Med. 37, 538\u2013554 (2016).","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"52071_CR2","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/irv.12514","volume":"11","author":"Y Pan","year":"2017","unstructured":"Pan, Y. et al. Human parainfluenza virus infection in severe acute respiratory infection cases in Beijing, 2014-2016: a molecular epidemiological study. Influenza Other Respir. Viruses 11, 564\u2013568 (2017).","journal-title":"Influenza Other Respir. Viruses"},{"key":"52071_CR3","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1177\/0009922812441674","volume":"52","author":"S Ben-Shimol","year":"2013","unstructured":"Ben-Shimol, S., Landau, D., Zilber, S. & Greenberg, D. Parainfluenza virus type 3 outbreak in a neonatal nursery. Clin. Pediatr. 52, 866\u2013870 (2013).","journal-title":"Clin. Pediatr."},{"key":"52071_CR4","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1111\/ped.13389","volume":"59","author":"H Maeda","year":"2017","unstructured":"Maeda, H., Haneda, K. & Honda, Y. Parainfluenza virus type 3 outbreak in a neonatal intensive care unit. Pediatr. Int. 59, 1219\u20131222 (2017).","journal-title":"Pediatr. Int."},{"key":"52071_CR5","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1128\/CMR.16.2.242-264.2003","volume":"16","author":"KJ Henrickson","year":"2003","unstructured":"Henrickson, K. J. Parainfluenza viruses. Clin. Microbiol. Rev. 16, 242\u2013264 (2003).","journal-title":"Clin. Microbiol. Rev."},{"key":"52071_CR6","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1099\/0022-1317-64-7-1557","volume":"64","author":"B Morein","year":"1983","unstructured":"Morein, B., Sharp, M., Sundquist, B. & Simons, K. Protein subunit vaccines of parainfluenza type 3 virus: immunogenic effect in lambs and mice. J. Gen. Virol. 64, 1557\u20131569 (1983).","journal-title":"J. Gen. Virol."},{"key":"52071_CR7","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3389\/fmicb.2013.00346","volume":"4","author":"K Senchi","year":"2013","unstructured":"Senchi, K., Matsunaga, S., Hasegawa, H., Kimura, H. & Ryo, A. Development of oligomannose-coated liposome-based nasal vaccine against human parainfluenza virus type 3. Front. Microbiol. 4, 346 (2013).","journal-title":"Front. Microbiol."},{"key":"52071_CR8","doi-asserted-by":"publisher","first-page":"12265","DOI":"10.1073\/pnas.1811980115","volume":"115","author":"GBE Stewart-Jones","year":"2018","unstructured":"Stewart-Jones, G. B. E. et al. Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1-4. Proc. Natl. Acad. Sci. USA 115, 12265\u201312270 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"52071_CR9","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.antiviral.2018.12.010","volume":"162","author":"R Garg","year":"2019","unstructured":"Garg, R. et al. Maternal vaccination with a novel chimeric glycoprotein formulated with a polymer-based adjuvant provides protection from human parainfluenza virus type 3 in newborn lambs. Antivir. Res. 162, 54\u201360 (2019).","journal-title":"Antivir. Res."},{"key":"52071_CR10","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1128\/iai.14.1.212-216.1976","volume":"14","author":"WP Glezen","year":"1976","unstructured":"Glezen, W. P. & Fernald, G. W. Effect of passive antibody on parainfluenza virus type 3 pneumonia in hamsters. Infect. Immun. 14, 212\u2013216 (1976).","journal-title":"Infect. Immun."},{"key":"52071_CR11","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1128\/jvi.65.1.103-111.1991","volume":"65","author":"DD Porter","year":"1991","unstructured":"Porter, D. D., Prince, G. A., Hemming, V. G. & Porter, H. G. Pathogenesis of human parainfluenza virus 3 infection in two species of cotton rats: Sigmodon hispidus develops bronchiolitis, while Sigmodon fulviventer develops interstitial pneumonia. J. Virol. 65, 103\u2013111 (1991).","journal-title":"J. Virol."},{"key":"52071_CR12","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/0264-410X(91)90037-7","volume":"9","author":"MW Ambrose","year":"1991","unstructured":"Ambrose, M. W. et al. Evaluation of the immunogenicity and protective efficacy of a candidate parainfluenza virus type 3 subunit vaccine in cotton rats. Vaccine 9, 505\u2013511 (1991).","journal-title":"Vaccine"},{"key":"52071_CR13","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1086\/345834","volume":"186","author":"MG Ottolini","year":"2002","unstructured":"Ottolini, M. G., Porter, D. D., Blanco, J. C. & Prince, G. A. A cotton rat model of human parainfluenza 3 laryngotracheitis: virus growth, pathology, and therapy. J. Infect. Dis. 186, 1713\u20131717 (2002).","journal-title":"J. Infect. Dis."},{"key":"52071_CR14","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.antiviral.2013.09.014","volume":"100","author":"BG Jones","year":"2013","unstructured":"Jones, B. G., Hayden, R. T. & Hurwitz, J. L. Inhibition of primary clinical isolates of human parainfluenza virus by DAS181 in cell culture and in a cotton rat model. Antivir. Res. 100, 562\u2013566 (2013).","journal-title":"Antivir. Res."},{"key":"52071_CR15","doi-asserted-by":"publisher","first-page":"e0383121","DOI":"10.1128\/mbio.03831-21","volume":"13","author":"LC Rijsbergen","year":"2021","unstructured":"Rijsbergen, L. C. et al. Modeling infection and tropism of human parainfluenza virus type 3 in ferrets. mBio 13, e0383121 (2021).","journal-title":"mBio"},{"key":"52071_CR16","first-page":"445","volume":"43","author":"EM Kudlacz","year":"1993","unstructured":"Kudlacz, E. M., Baugh, L. E., Porter, W. P., Kenny, M. T. & Farrell, A. M. A time-course study of airway hyperresponsiveness in conscious parainfluenza virus type 3-infected guinea pigs. Lab Anim. Sci. 43, 445\u2013453 (1993).","journal-title":"Lab Anim. Sci."},{"key":"52071_CR17","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3109\/01902148.2010.540768","volume":"37","author":"XM Ye","year":"2011","unstructured":"Ye, X. M., Zhong, N. S., Liu, C. L. & Chen, R. C. Cough reflex sensitivity is increased in guinea pigs with parainfluenza virus infection. Exp. Lung Res. 37, 186\u2013194 (2011).","journal-title":"Exp. Lung Res."},{"key":"52071_CR18","doi-asserted-by":"publisher","first-page":"e0155526","DOI":"10.1371\/journal.pone.0155526","volume":"11","author":"EJ Zaccone","year":"2016","unstructured":"Zaccone, E. J. et al. Parainfluenza 3-induced cough hypersensitivity in the guinea pig airways. PLoS ONE 11, e0155526 (2016).","journal-title":"PLoS ONE"},{"key":"52071_CR19","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1016\/S0264-410X(99)00575-7","volume":"18","author":"AP Durbin","year":"2000","unstructured":"Durbin, A. P., Elkins, W. R. & Murphy, B. R. African green monkeys provide a useful nonhuman primate model for the study of human parainfluenza virus types-1, -2, and -3 infection. Vaccine 18, 2462\u20132469 (2000).","journal-title":"Vaccine"},{"key":"52071_CR20","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/infdis\/157.4.655","volume":"157","author":"KL van Wyke Coelingh","year":"1988","unstructured":"van Wyke Coelingh, K. L., Winter, C. C., Tierney, E. L., London, W. T. & Murphy, B. R. Attenuation of bovine parainfluenza virus type 3 in nonhuman primates and its ability to confer immunity to human parainfluenza virus type 3 challenge. J. Infect. Dis. 157, 655\u2013662 (1988).","journal-title":"J. Infect. Dis."},{"key":"52071_CR21","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/S0264-410X(98)00010-3","volume":"16","author":"AP Durbin","year":"1998","unstructured":"Durbin, A. P., Wyatt, L. S., Siew, J., Moss, B. & Murphy, B. R. The immunogenicity and efficacy of intranasally or parenterally administered replication-deficient vaccinia-parainfluenza virus type 3 recombinants in rhesus monkeys. Vaccine 16, 1324\u20131330 (1998).","journal-title":"Vaccine"},{"key":"52071_CR22","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.antiviral.2018.07.021","volume":"158","author":"R Garg","year":"2018","unstructured":"Garg, R. et al. A chimeric glycoprotein formulated with a combination adjuvant induces protective immunity against both human respiratory syncytial virus and parainfluenza virus type 3. Antivir. Res. 158, 78\u201387 (2018).","journal-title":"Antivir. Res."},{"key":"52071_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1600-065X.1995.tb00090.x","volume":"148","author":"MF van den Broek","year":"1995","unstructured":"van den Broek, M. F., M\u00fcller, U., Huang, S., Zinkernagel, R. M. & Aguet, M. Immune defence in mice lacking type I and\/or type II interferon receptors. Immunol. Rev. 148, 5\u201318 (1995).","journal-title":"Immunol. Rev."},{"key":"52071_CR24","doi-asserted-by":"publisher","first-page":"5803","DOI":"10.1128\/JVI.00289-14","volume":"88","author":"T Meng","year":"2014","unstructured":"Meng, T. & Kwang, J. Attenuation of human enterovirus 71 high-replication-fidelity variants in AG129 mice. J. Virol. 88, 5803\u20135815 (2014).","journal-title":"J. Virol."},{"key":"52071_CR25","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/s41586-021-03990-6","volume":"598","author":"SJF Kaptein","year":"2021","unstructured":"Kaptein, S. J. F. et al. A pan-serotype dengue virus inhibitor targeting the NS3-NS4B interaction. Nature 598, 504\u2013509 (2021).","journal-title":"Nature"},{"key":"52071_CR26","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3390\/pathogens11080879","volume":"11","author":"LVR Baldon","year":"2022","unstructured":"Baldon, L. V. R. et al. AG129 mice as a comprehensive model for the experimental assessment of mosquito vector competence for arboviruses. Pathogens 11, 879 (2022).","journal-title":"Pathogens"},{"key":"52071_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26760-4","volume":"12","author":"RM Cox","year":"2021","unstructured":"Cox, R. M. et al. Oral prodrug of remdesivir parent GS-441524 is efficacious against SARS-CoV-2 in ferrets. Nat. Commun. 12, 6415 (2021).","journal-title":"Nat. Commun."},{"key":"52071_CR28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jmoldx.2011.08.002","volume":"14","author":"F Wang","year":"2012","unstructured":"Wang, F. et al. RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. J. Mol. Diagn. 14, 22\u201329 (2012).","journal-title":"J. Mol. Diagn."},{"key":"52071_CR29","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.1016\/S2213-2600(21)00240-X","volume":"9","author":"LJ Ceulemans","year":"2021","unstructured":"Ceulemans, L. J. et al. Persistence of SARS-CoV-2 RNA in lung tissue after mild COVID-19. Lancet Respir. Med. 9, e78\u2013e79 (2021).","journal-title":"Lancet Respir. Med."},{"key":"52071_CR30","doi-asserted-by":"publisher","first-page":"5932","DOI":"10.1016\/j.cell.2021.10.027","volume":"184","author":"M Khan","year":"2021","unstructured":"Khan, M. et al. Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb. Cell 184, 5932\u20135949.e5915 (2021).","journal-title":"Cell"},{"key":"52071_CR31","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.1016\/j.neuron.2022.11.007","volume":"110","author":"M Khan","year":"2022","unstructured":"Khan, M. et al. Anatomical barriers against SARS-CoV-2 neuroinvasion at vulnerable interfaces visualized in deceased COVID-19 patients. Neuron 110, 3919\u20133935.e3916 (2022).","journal-title":"Neuron"},{"key":"52071_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104608","volume":"92","author":"J Van Slambrouck","year":"2023","unstructured":"Van Slambrouck, J. et al. Visualising SARS-CoV-2 infection of the lung in deceased COVID-19 patients. EBioMedicine 92, 104608 (2023).","journal-title":"EBioMedicine"},{"key":"52071_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2023.102831","volume":"5","author":"M Clijsters","year":"2024","unstructured":"Clijsters, M. et al. Protocol for postmortem bedside endoscopic procedure to sample human respiratory and olfactory cleft mucosa, olfactory bulbs, and frontal lobe. STAR Protoc. 5, 102831 (2024).","journal-title":"STAR Protoc."},{"key":"52071_CR34","unstructured":"Administration, U. S. F. D. FDA Approves First Treatment for COVID-19. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-treatment-covid-19 (2020)."},{"key":"52071_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/srep43395","volume":"7","author":"MK Lo","year":"2017","unstructured":"Lo, M. K. et al. GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses. Sci. Rep. 7, 43395 (2017).","journal-title":"Sci. Rep."},{"key":"52071_CR36","doi-asserted-by":"publisher","first-page":"e112907","DOI":"10.15252\/embj.2022112907","volume":"42","author":"L Dalskov","year":"2023","unstructured":"Dalskov, L., Gad, H. H. & Hartmann, R. Viral recognition and the antiviral interferon response. EMBO J. 42, e112907 (2023).","journal-title":"EMBO J."},{"key":"52071_CR37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12950-015-0054-7","volume":"12","author":"A Lewandowska-Polak","year":"2015","unstructured":"Lewandowska-Polak, A. et al. Human parainfluenza virus type 3 (HPIV3) induces production of IFN\u03b3 and RANTES in human nasal epithelial cells (HNECs). J. Inflamm. 12, 16 (2015).","journal-title":"J. Inflamm."},{"key":"52071_CR38","doi-asserted-by":"publisher","first-page":"4823","DOI":"10.1128\/JVI.75.10.4823-4831.2001","volume":"75","author":"S Choudhary","year":"2001","unstructured":"Choudhary, S., Gao, J., Leaman, D. W. & De, B. P. Interferon action against human parainfluenza virus type 3: involvement of a novel antiviral pathway in the inhibition of transcription. J. Virol. 75, 4823\u20134831 (2001).","journal-title":"J. Virol."},{"key":"52071_CR39","doi-asserted-by":"publisher","first-page":"11145","DOI":"10.1128\/JVI.01551-16","volume":"90","author":"MA Rabbani","year":"2016","unstructured":"Rabbani, M. A., Ribaudo, M., Guo, J. T. & Barik, S. Identification of interferon-stimulated gene proteins that Inhibit human parainfluenza virus type 3. J. Virol. 90, 11145\u201311156 (2016).","journal-title":"J. Virol."},{"key":"52071_CR40","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/S0022-3476(99)70064-8","volume":"135","author":"SE Dorman","year":"1999","unstructured":"Dorman, S. E. et al. Viral infections in interferon-gamma receptor deficiency. J. Pediatr. 135, 640\u2013643 (1999).","journal-title":"J. Pediatr."},{"key":"52071_CR41","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3324\/haematol.2008.003319","volume":"94","author":"A Piralla","year":"2009","unstructured":"Piralla, A., Percivalle, E., Di Cesare-Merlone, A., Locatelli, F. & Gerna, G. Multicluster nosocomial outbreak of parainfluenza virus type 3 infection in a pediatric oncohematology unit: a phylogenetic study. Haematologica 94, 833\u2013839 (2009).","journal-title":"Haematologica"},{"key":"52071_CR42","doi-asserted-by":"publisher","first-page":"6371","DOI":"10.1002\/jmv.27243","volume":"93","author":"C Lefeuvre","year":"2021","unstructured":"Lefeuvre, C. et al. Frequent lower respiratory tract disease in hematological patients with parainfluenza virus type 3 infection. J. Med. Virol. 93, 6371\u20136376 (2021).","journal-title":"J. Med. Virol."},{"key":"52071_CR43","doi-asserted-by":"publisher","first-page":"e150506","DOI":"10.1172\/JCI150506","volume":"131","author":"AL Greninger","year":"2021","unstructured":"Greninger, A. L. et al. Human parainfluenza virus evolution during lung infection of immunocompromised individuals promotes viral persistence. J. Clin. Invest. 131, e150506 (2021).","journal-title":"J. Clin. Invest."},{"key":"52071_CR44","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1128\/JVI.79.2.1113-1124.2005","volume":"79","author":"L Zhang","year":"2005","unstructured":"Zhang, L. et al. Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium. J. Virol. 79, 1113\u20131124 (2005).","journal-title":"J. Virol."},{"key":"52071_CR45","doi-asserted-by":"publisher","first-page":"e00723-19","DOI":"10.1128\/mBio.00723-19","volume":"10","author":"M Porotto","year":"2019","unstructured":"Porotto, M. et al. Authentic modeling of human respiratory virus infection in human pluripotent stem cell-derived lung organoids. mBio 10, e00723-19 (2019).","journal-title":"mBio"},{"key":"52071_CR46","first-page":"384","volume":"33","author":"CC Mascoli","year":"1976","unstructured":"Mascoli, C. C., Gower, T. A., Capilupo, F. A. & Metzgar, D. P. Further studies on the neonatal ferret model of infection and immunity to and attenuation of human parainfluenza viruses. Dev. Biol. Stand. 33, 384\u2013390 (1976).","journal-title":"Dev. Biol. Stand."},{"key":"52071_CR47","doi-asserted-by":"publisher","first-page":"e00221-18","DOI":"10.1128\/mBio.00221-18","volume":"9","author":"ML Agostini","year":"2018","unstructured":"Agostini, M. L. et al. Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease. mBio 9, e00221-18 (2018).","journal-title":"mBio"},{"key":"52071_CR48","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1021\/acsmedchemlett.0c00316","volume":"11","author":"VC Yan","year":"2020","unstructured":"Yan, V. C. & Muller, F. L. Advantages of the parent nucleoside GS-441524 over remdesivir for Covid-19 treatment. ACS Med. Chem. Lett. 11, 1361\u20131366 (2020).","journal-title":"ACS Med. Chem. Lett."},{"key":"52071_CR49","doi-asserted-by":"publisher","first-page":"100128","DOI":"10.1016\/j.onehlt.2020.100128","volume":"9","author":"ES Amirian","year":"2020","unstructured":"Amirian, E. S. & Levy, J. K. Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses. One Health 9, 100128 (2020).","journal-title":"One Health"},{"key":"52071_CR50","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1021\/acs.jmedchem.0c01929","volume":"65","author":"Y Li","year":"2022","unstructured":"Li, Y. et al. Remdesivir metabolite GS-441524 effectively inhibits SARS-CoV-2 infection in mouse models. J. Med. Chem. 65, 2785\u20132793 (2022).","journal-title":"J. Med. Chem."},{"key":"52071_CR51","doi-asserted-by":"publisher","unstructured":"Martinez, D. R. et al. Efficacy of the oral nucleoside prodrug GS-5245 (Obeldesivir) against SARS-CoV-2 and coronaviruses with pandemic potential. bioRxiv https:\/\/doi.org\/10.1101\/2023.06.27.546784 (2023).","DOI":"10.1101\/2023.06.27.546784"},{"key":"52071_CR52","doi-asserted-by":"publisher","first-page":"11701","DOI":"10.1021\/acs.jmedchem.3c00750","volume":"66","author":"RL Mackman","year":"2023","unstructured":"Mackman, R. L. et al. Discovery of GS-5245 (Obeldesivir), an oral prodrug of nucleoside GS-441524 that exhibits antiviral efficacy in SARS-CoV-2-infected African green monkeys. J. Med. Chem. 66, 11701\u201311717 (2023).","journal-title":"J. Med. Chem."},{"key":"52071_CR53","unstructured":"Medicine, U. S. N. L. O. Study of obeldesivir in nonhospitalized participants with COVID-19 (OAKTREE). https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05715528 (2023)."},{"key":"52071_CR54","doi-asserted-by":"publisher","unstructured":"Pitts, J. Efficacy in multiple SARS-CoV-2 animal models supports phase 3 dose selection for obeldesivir. Open Forum Infect. Dis. https:\/\/doi.org\/10.1093\/ofid\/ofad500.608 (2023).","DOI":"10.1093\/ofid\/ofad500.608"},{"key":"52071_CR55","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1038\/bmt.2013.112","volume":"48","author":"J Casey","year":"2013","unstructured":"Casey, J., Morris, K., Narayana, M., Nakagaki, M. & Kennedy, G. A. Oral ribavirin for treatment of respiratory syncitial virus and parainfluenza 3 virus infections post allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant. 48, 1558\u20131561 (2013).","journal-title":"Bone Marrow Transplant."},{"key":"52071_CR56","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/s41409-020-01022-x","volume":"56","author":"M Stamouli","year":"2021","unstructured":"Stamouli, M. et al. Oral ribavirin is a highly effective treatment for lower respiratory tract infections due to respiratory syncytial virus or parainfluenza after allogeneic stem cell transplantation. Bone Marrow Transplant. 56, 511\u2013513 (2021).","journal-title":"Bone Marrow Transplant."},{"key":"52071_CR57","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1097\/00007890-201407151-02650","volume":"98","author":"E Kwak","year":"2014","unstructured":"Kwak, E., Abdel-Massih, R., Crespo, M., Pilewski, J. & Nguyen, M. Oral ribavirin for treatment of respiratory viral infection in lung transplant recipients.: Abstract# D2407. Transplantation 98, 775 (2014).","journal-title":"Transplantation"},{"key":"52071_CR58","first-page":"1172","volume":"137","author":"JA Frank Jr.","year":"1983","unstructured":"Frank, J. A. Jr., Warren, R. W., Tucker, J. A., Zeller, J. & Wilfert, C. M. Disseminated parainfluenza infection in a child with severe combined immunodeficiency. Am. J. Dis. Child 137, 1172\u20131174 (1983).","journal-title":"Am. J. Dis. Child"},{"key":"52071_CR59","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2147\/IDR.S25874","volume":"5","author":"AR Falsey","year":"2012","unstructured":"Falsey, A. R. Current management of parainfluenza pneumonitis in immunocompromised patients: a review. Infect. Drug Resist. 5, 121\u2013127 (2012).","journal-title":"Infect. Drug Resist."},{"key":"52071_CR60","doi-asserted-by":"publisher","first-page":"e00898-18","DOI":"10.1128\/mBio.00898-18","volume":"9","author":"S Iketani","year":"2018","unstructured":"Iketani, S. et al. Viral entry properties required for fitness in humans are lost through rapid genomic change during viral isolation. mBio 9, e00898-18 (2018).","journal-title":"mBio"},{"key":"52071_CR61","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1165\/rcmb.2020-0280LE","volume":"63","author":"AD Gruber","year":"2020","unstructured":"Gruber, A. D. et al. Standardization of reporting criteria for lung pathology in SARS-CoV-2-infected hamsters: what matters? Am. J. Respir. Cell Mol. Biol. 63, 856\u2013859 (2020).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"52071_CR62","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abm3410","volume":"14","author":"A Sch\u00e4fer","year":"2022","unstructured":"Sch\u00e4fer, A. et al. Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in mice. Sci. Transl. Med. 14, eabm3410 (2022).","journal-title":"Sci. Transl. Med."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52071-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52071-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52071-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T11:16:48Z","timestamp":1725535008000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52071-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,5]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["52071"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-52071-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4189135\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,5]]},"assertion":[{"value":"18 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.B. and J.B. are employees of Gilead Sciences which owns GS-441524. None of the other authors have any competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7765"}}